Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= PD-1
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(12)
+
-
Availability
Open access
(8)
+
-
Metadata Only
(5)
+
-
Creation Date
2017
(4)
+
-
2018
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(12)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(12)
+
-
Topic
PD-1
(13)
+
-
PD-L1
(4)
+
-
immunotherapy
(4)
+
-
Biomarker
(2)
+
-
Cervical cancer
(2)
+
-
Immunotherapy
(2)
+
-
checkpoint blockade
(2)
+
-
expression
(2)
+
-
follicular helper T cell
(2)
+
-
Show more
Author
Ossendorp, F.
(3)
+
-
Bosse, T.
(2)
+
-
Burg, S.H. van der
(2)
+
-
Cetinozman, F.
(2)
+
-
Fransen, M.F.
(2)
+
-
Hall, T. van
(2)
+
-
Jansen, P.M.
(2)
+
-
Kleinovink, J.W.
(2)
+
-
Poelgeest, M.I.E. van
(2)
+
-
Willemze, R.
(2)
+
-
Show more
Language
en
(13)
+
-
Search results
(1 - 13 of 13)
show grid
show list
save search
Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy
PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status
Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events
Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8(+) T Cells During Relapse after Allogeneic Stem Cell Transplantation
Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
PD-L1 immune suppression in cancer: Tumor cells or host cells?
PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma
KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults
Deregulation of innate and adaptive immune responses in human papillomavirus infection and cancer
Programmed death-1 expression in cutaneous B-cell lymphoma
Expression of Programmed Death-1 in Primary Cutaneous CD4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoma, Cutaneous Pseudo-T-Cell Lymphoma, and Other Types of Cutaneous T-Cell Lymphoma